FHIR IG analytics| Package | noma.fhir.mpd |
| Resource Type | CodeSystem |
| Id | ATC_Musculo_Skeletal_System.json |
| FHIR Version | R4 |
| Source | https://simplifier.net/resolve?scope=noma.fhir.mpd@2.0.0&canonical=https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64 |
| URL | https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64 |
| Status | active |
| Name | Anatomical Therapeutic Chemical classification system - Human - Musculo-skeletal system Examples |
| Content | complete |
No resources found
No resources found
No narrative content found in resource
FHIR
FHIRsmith{
"resourceType": "CodeSystem",
"id": "82311936-f7e3-4c24-8821-229f055f7c64",
"meta": {
"versionId": "1",
"lastUpdated": "2025-08-11T08:38:18.798+00:00"
},
"url": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"identifier": [
{
"system": "http://legemiddelverket.no/fhir/SAFEST/SafestCodeSystemID",
"value": "82311936-f7e3-4c24-8821-229f055f7c64"
},
{
"system": "http://legemiddelverket.no/fhir/SAFEST/ListID",
"value": "100000096652"
}
],
"name": "Anatomical Therapeutic Chemical classification system - Human - Musculo-skeletal system Examples",
"status": "active",
"content": "complete",
"property": [
{
"code": "parentATC",
"description": "Parent ATC",
"type": "Coding"
},
{
"code": "fromDate",
"description": "From Date",
"type": "Coding"
},
{
"code": "toDate",
"description": "To Date",
"type": "Coding"
},
{
"code": "previousVersion",
"description": "Previous Version",
"type": "Coding"
},
{
"code": "ATCCode",
"description": "ATC Code",
"type": "Coding"
},
{
"code": "internalCode",
"description": "Internal code",
"type": "Coding"
},
{
"code": "termIdRms",
"description": "RMS ID",
"type": "Coding"
},
{
"code": "internalTermStatus",
"description": "Status (internal)",
"type": "Coding"
},
{
"code": "sourceTermStatus",
"description": "Status (RMS)",
"type": "Coding"
}
],
"concept": [
{
"code": "M01AX23",
"display": "Tenidap",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Tenidap"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Tenidap"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AX",
"display": "Other antiinflammatory and antirheumatic agents, non-steroids"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AX23",
"display": "M01AX23"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AX23"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AE53",
"display": "Ketoprofen, combinations",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Ketoprofen, combinations"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Ketoprofen, kombinasjoner"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AE",
"display": "Propionic acid derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AE53",
"display": "M01AE53"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AE53"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M05BX",
"display": "Other drugs affecting bone structure and mineralization",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Other drugs affecting bone structure and mineralization"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Andre midler med effekt på benstruktur og mineralisering"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M05B",
"display": "Drugs affecting bone structure and mineralization"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M05BX",
"display": "M05BX"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M05BX"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AG03",
"display": "Flufenamic acid",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Flufenamic acid"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Flufenamsyre"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AG",
"display": "Fenamates"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AG03",
"display": "M01AG03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AG03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M09AA72",
"display": "Quinine, combinations with psycholeptics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Quinine, combinations with psycholeptics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Kinin, kombinasjoner med psykoleptika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M09AA",
"display": "Quinine and derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M09AA72",
"display": "M09AA72"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M09AA72"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M09AB02",
"display": "Collagenase clostridium histolyticum",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Collagenase clostridium histolyticum"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Kollagenase klostridum histolyticum"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M09AB",
"display": "Enzymes"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M09AB02",
"display": "M09AB02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2011-01-01T00:00:00Z",
"display": "2011-01-01T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M09AB02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M02AA25",
"display": "Aceclofenac",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Aceclofenac"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Aceklofenak"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M02AA",
"display": "Antiinflammatory preparations, non-steroids for topical use"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M02AA25",
"display": "M02AA25"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2007-03-04T00:00:00Z",
"display": "2007-03-04T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M02AA25"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M05BA01",
"display": "Etidronic acid",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Etidronic acid"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Etidronsyre"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M05BA",
"display": "Bisphosphonates"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M05BA01",
"display": "M05BA01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M05BA01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M02AA27",
"display": "Dexketoprofen",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Dexketoprofen"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Deksketoprofen"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M02AA",
"display": "Antiinflammatory preparations, non-steroids for topical use"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M02AA27",
"display": "M02AA27"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2014-02-20T00:00:00Z",
"display": "2014-02-20T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M02AA27"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M03CA01",
"display": "Dantrolene",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Dantrolene"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Dantrolen"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M03CA",
"display": "Dantrolene and derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M03CA01",
"display": "M03CA01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M03CA01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AC05",
"display": "Lornoxicam",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Lornoxicam"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Lornoksikam"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AC",
"display": "Oxicams"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AC05",
"display": "M01AC05"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AC05"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M05BX03",
"display": "Strontium ranelate",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Strontium ranelate"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Strontiumranelat"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M05BX",
"display": "Other drugs affecting bone structure and mineralization"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M05BX03",
"display": "M05BX03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2004-11-09T00:00:00Z",
"display": "2004-11-09T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M05BX03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M03BX06",
"display": "Mephenesin",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Mephenesin"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Mefenesin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M03BX",
"display": "Other centrally acting agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M03BX06",
"display": "M03BX06"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M03BX06"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AE19",
"display": "Loxoprofen",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Loxoprofen"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Loksoprofen"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AE",
"display": "Propionic acid derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AE19",
"display": "M01AE19"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2024-11-19T00:00:00Z",
"display": "2024-11-19T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AE19"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M03BC01",
"display": "Orphenadrine (citrate)",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Orphenadrine (citrate)"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Orfenadrin (citrat)"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M03BC",
"display": "Ethers, chemically close to antihistamines"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M03BC01",
"display": "M03BC01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M03BC01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M02AX06",
"display": "Tolperisone",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Tolperisone"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Tolperison"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M02AX",
"display": "Other topical products for joint and muscular pain"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M02AX06",
"display": "M02AX06"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2013-12-10T00:00:00Z",
"display": "2013-12-10T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M02AX06"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M09AX03",
"display": "Ataluren",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Ataluren"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Ataluren"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M09AX",
"display": "Other drugs for disorders of the musculo-skeletal system"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M09AX03",
"display": "M09AX03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2015-01-22T00:00:00Z",
"display": "2015-01-22T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M09AX03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M09AX",
"display": "Other drugs for disorders of the musculo-skeletal system",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Other drugs for disorders of the musculo-skeletal system"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Andre midler mot muskel- og skjelettsykdommer"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M09A",
"display": "Other drugs for disorders of the musculo-skeletal system"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M09AX",
"display": "M09AX"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M09AX"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M02AA09",
"display": "Bufexamac",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Bufexamac"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Bufeksamak"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M02AA",
"display": "Antiinflammatory preparations, non-steroids for topical use"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M02AA09",
"display": "M02AA09"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M02AA09"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M02AA07",
"display": "Piroxicam",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Piroxicam"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Piroksikam"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M02AA",
"display": "Antiinflammatory preparations, non-steroids for topical use"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M02AA07",
"display": "M02AA07"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M02AA07"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M02AA29",
"display": "Esflurbiprofen",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Esflurbiprofen"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Esflurbiprofen"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M02AA",
"display": "Antiinflammatory preparations, non-steroids for topical use"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M02AA29",
"display": "M02AA29"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2020-11-11T00:00:00Z",
"display": "2020-11-11T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M02AA29"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M03AC10",
"display": "Mivacurium chloride",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Mivacurium chloride"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Mivakuriumklorid"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M03AC",
"display": "Other quaternary ammonium compounds"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M03AC10",
"display": "M03AC10"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M03AC10"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01CB04",
"display": "Aurothioglucose",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Aurothioglucose"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Aurotioglukose"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01CB",
"display": "Gold preparations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01CB04",
"display": "M01CB04"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01CB04"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M03AA02",
"display": "Tubocurarine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Tubocurarine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Tubokurarin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M03AA",
"display": "Curare alkaloids"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M03AA02",
"display": "M03AA02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M03AA02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M04AB02",
"display": "Sulfinpyrazone",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Sulfinpyrazone"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Sulfinpyrazon"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M04AB",
"display": "Preparations increasing uric acid excretion"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M04AB02",
"display": "M04AB02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M04AB02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M04AB05",
"display": "Lesinurad",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Lesinurad"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Lesinurad"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M04AB",
"display": "Preparations increasing uric acid excretion"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M04AB05",
"display": "M04AB05"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2015-07-06T00:00:00Z",
"display": "2015-07-06T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M04AB05"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M02AB02",
"display": "Zucapsaicin",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Zucapsaicin"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Zukapsaicin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M02AB",
"display": "Capsaicin and similar agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M02AB02",
"display": "M02AB02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2009-03-23T00:00:00Z",
"display": "2009-03-23T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M02AB02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M02AA03",
"display": "Clofezone",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Clofezone"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Klofezon"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M02AA",
"display": "Antiinflammatory preparations, non-steroids for topical use"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M02AA03",
"display": "M02AA03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M02AA03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AE10",
"display": "Indoprofen",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Indoprofen"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Indoprofen"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AE",
"display": "Propionic acid derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AE10",
"display": "M01AE10"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AE10"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AE56",
"display": "Naproxen and misoprostol",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Naproxen and misoprostol"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Naproksen og misoprostol"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AE",
"display": "Propionic acid derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AE56",
"display": "M01AE56"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2012-01-01T00:00:00Z",
"display": "2012-01-01T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AE56"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M04AB04",
"display": "Isobromindione",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Isobromindione"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Isobromindion"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M04AB",
"display": "Preparations increasing uric acid excretion"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M04AB04",
"display": "M04AB04"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M04AB04"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AE13",
"display": "Ibuproxam",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Ibuproxam"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Ibuproksam"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AE",
"display": "Propionic acid derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AE13",
"display": "M01AE13"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AE13"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M09AX04",
"display": "Drisapersen",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Drisapersen"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Drisapersen"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M09AX",
"display": "Other drugs for disorders of the musculo-skeletal system"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M09AX04",
"display": "M09AX04"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2015-07-06T00:00:00Z",
"display": "2015-07-06T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M09AX04"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AX12",
"display": "Glucosaminoglycan polysulfate",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Glucosaminoglycan polysulfate"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Glukosaminglykanpolysulfat"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AX",
"display": "Other antiinflammatory and antirheumatic agents, non-steroids"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AX12",
"display": "M01AX12"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AX12"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M04AB",
"display": "Preparations increasing uric acid excretion",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Preparations increasing uric acid excretion"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Midler som øker urinsyreutskillelsen"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M04A",
"display": "Antigout preparations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M04AB",
"display": "M04AB"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M04AB"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AX68",
"display": "Feprazone, combinations",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Feprazone, combinations"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Feprazon, kombinasjoner"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AX",
"display": "Other antiinflammatory and antirheumatic agents, non-steroids"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AX68",
"display": "M01AX68"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AX68"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01CB01",
"display": "Sodium aurothiomalate",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Sodium aurothiomalate"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Natriumaurotiomalat"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01CB",
"display": "Gold preparations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01CB01",
"display": "M01CB01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01CB01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AE57",
"display": "Naproxen and diphenhydramine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Naproxen and diphenhydramine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Naproksen og difenhydramin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AE",
"display": "Propionic acid derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AE57",
"display": "M01AE57"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2023-12-05T00:00:00Z",
"display": "2023-12-05T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AE57"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01A",
"display": "Antiinflammatory and antirheumatic products, non-steroids",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Antiinflammatory and antirheumatic products, non-steroids"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Antiinflammatoriske og antireumatiske midler, ikke- steroider"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01",
"display": "Antiinflammatory and antirheumatic products"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01A",
"display": "M01A"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01A"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AB51",
"display": "Indometacin, combinations",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Indometacin, combinations"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Indometacin, kombinasjoner"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AB",
"display": "Acetic acid derivatives and related substances"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AB51",
"display": "M01AB51"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AB51"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M03BA73",
"display": "Methocarbamol, combinations with psycholeptics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Methocarbamol, combinations with psycholeptics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Metokarbamol, kombinasjoner med psykoleptika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M03BA",
"display": "Carbamic acid esters"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M03BA73",
"display": "M03BA73"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M03BA73"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AB05",
"display": "Diclofenac",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Diclofenac"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Diklofenak"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AB",
"display": "Acetic acid derivatives and related substances"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AB05",
"display": "M01AB05"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AB05"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AE17",
"display": "Dexketoprofen",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Dexketoprofen"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Deksketoprofen"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AE",
"display": "Propionic acid derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AE17",
"display": "M01AE17"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AE17"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M04AX",
"display": "Other antigout preparations",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Other antigout preparations"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Andre giktmidler"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M04A",
"display": "Antigout preparations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M04AX",
"display": "M04AX"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M04AX"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AE51",
"display": "Ibuprofen, combinations",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Ibuprofen, combinations"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Ibuprofen, kombinasjoner"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AE",
"display": "Propionic acid derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AE51",
"display": "M01AE51"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AE51"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M05BX04",
"display": "Denosumab",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Denosumab"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Denosumab"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M05BX",
"display": "Other drugs affecting bone structure and mineralization"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M05BX04",
"display": "M05BX04"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2010-01-01T00:00:00Z",
"display": "2010-01-01T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M05BX04"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M03BB02",
"display": "Chlormezanone",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Chlormezanone"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Klormezanon"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M03BB",
"display": "Oxazol, thiazine, and triazine derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M03BB02",
"display": "M03BB02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M03BB02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AB03",
"display": "Tolmetin",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Tolmetin"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Tolmetin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AB",
"display": "Acetic acid derivatives and related substances"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AB03",
"display": "M01AB03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AB03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M02AX10",
"display": "Various",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Various"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Diverse"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M02AX",
"display": "Other topical products for joint and muscular pain"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M02AX10",
"display": "M02AX10"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M02AX10"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AB14",
"display": "Proglumetacin",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Proglumetacin"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Proglumetacin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AB",
"display": "Acetic acid derivatives and related substances"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AB14",
"display": "M01AB14"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AB14"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M03AC06",
"display": "Pipecuronium bromide",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Pipecuronium bromide"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Pipekuroniumbromid"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M03AC",
"display": "Other quaternary ammonium compounds"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M03AC06",
"display": "M03AC06"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M03AC06"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M09AX10",
"display": "Risdiplam",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Risdiplam"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Risdiplam"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M09AX",
"display": "Other drugs for disorders of the musculo-skeletal system"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M09AX10",
"display": "M09AX10"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2020-11-11T00:00:00Z",
"display": "2020-11-11T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M09AX10"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M02AA18",
"display": "Meclofenamic acid",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Meclofenamic acid"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Meklofenamsyre"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M02AA",
"display": "Antiinflammatory preparations, non-steroids for topical use"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M02AA18",
"display": "M02AA18"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M02AA18"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M09AB",
"display": "Enzymes",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Enzymes"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Enzymer"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M09A",
"display": "Other drugs for disorders of the musculo-skeletal system"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M09AB",
"display": "M09AB"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M09AB"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M03BA52",
"display": "Carisoprodol, combinations excl. psycholeptics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Carisoprodol, combinations excl. psycholeptics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Karisoprodol, kombinasjoner ekskl. psykoleptika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M03BA",
"display": "Carbamic acid esters"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M03BA52",
"display": "M03BA52"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M03BA52"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M05BB03",
"display": "Alendronic acid and colecalciferol",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Alendronic acid and colecalciferol"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Alendronsyre og kolekalsiferol"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M05BB",
"display": "Bisphosphonates, combinations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M05BB03",
"display": "M05BB03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2007-01-01T00:00:00Z",
"display": "2007-01-01T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M05BB03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AB06",
"display": "Alclofenac",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Alclofenac"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Alklofenak"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AB",
"display": "Acetic acid derivatives and related substances"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AB06",
"display": "M01AB06"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AB06"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M03BA04",
"display": "Styramate",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Styramate"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Styramat"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M03BA",
"display": "Carbamic acid esters"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M03BA04",
"display": "M03BA04"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M03BA04"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AX02",
"display": "Niflumic acid",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Niflumic acid"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Nifluminsyre"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AX",
"display": "Other antiinflammatory and antirheumatic agents, non-steroids"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AX02",
"display": "M01AX02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AX02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M",
"display": "Musculo-skeletal system",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Musculo-skeletal system"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Muskler og skjelett"
}
],
"property": [
{
"code": "ATCCode",
"valueCoding": {
"code": "M",
"display": "M"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M02AA31",
"display": "Loxoprofen",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Loxoprofen"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Loksoprofen"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M02AA",
"display": "Antiinflammatory preparations, non-steroids for topical use"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M02AA31",
"display": "M02AA31"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2021-11-08T00:00:00Z",
"display": "2021-11-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M02AA31"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M03BC",
"display": "Ethers, chemically close to antihistamines",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Ethers, chemically close to antihistamines"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Etere, kjemisk nærstående antihistaminer"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M03B",
"display": "Muscle relaxants, centrally acting agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M03BC",
"display": "M03BC"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M03BC"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M04AC51",
"display": "Colchicine and probenecid",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Colchicine and probenecid"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Kolkisin og probenecid"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M04AC",
"display": "Preparations with no effect on uric acid metabolism"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M04AC51",
"display": "M04AC51"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2023-12-05T00:00:00Z",
"display": "2023-12-05T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M04AC51"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M03BX03",
"display": "Pridinol",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Pridinol"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Pridinol"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M03BX",
"display": "Other centrally acting agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M03BX03",
"display": "M03BX03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M03BX03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AX18",
"display": "Feprazone",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Feprazone"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Feprazon"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AX",
"display": "Other antiinflammatory and antirheumatic agents, non-steroids"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AX18",
"display": "M01AX18"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AX18"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M09AX05",
"display": "Aceneuramic acid",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Aceneuramic acid"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Aceneuraminsyre"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M09AX",
"display": "Other drugs for disorders of the musculo-skeletal system"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M09AX05",
"display": "M09AX05"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2016-02-10T00:00:00Z",
"display": "2016-02-10T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M09AX05"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AB11",
"display": "Acemetacin",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Acemetacin"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Acemetacin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AB",
"display": "Acetic acid derivatives and related substances"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AB11",
"display": "M01AB11"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AB11"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M04AA",
"display": "Preparations inhibiting uric acid production",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Preparations inhibiting uric acid production"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Midler som hemmer urinsyreproduksjonen"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M04A",
"display": "Antigout preparations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M04AA",
"display": "M04AA"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M04AA"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AC02",
"display": "Tenoxicam",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Tenoxicam"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Tenoksikam"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AC",
"display": "Oxicams"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AC02",
"display": "M01AC02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AC02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M03BB",
"display": "Oxazol, thiazine, and triazine derivatives",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Oxazol, thiazine, and triazine derivatives"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Oksazol-, tiazin- og triazinderivater"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M03B",
"display": "Muscle relaxants, centrally acting agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M03BB",
"display": "M03BB"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M03BB"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AE01",
"display": "Ibuprofen",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Ibuprofen"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Ibuprofen"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AE",
"display": "Propionic acid derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AE01",
"display": "M01AE01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AE01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M04AA01",
"display": "Allopurinol",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Allopurinol"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Allopurinol"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M04AA",
"display": "Preparations inhibiting uric acid production"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M04AA01",
"display": "M04AA01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M04AA01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AA02",
"display": "Mofebutazone",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Mofebutazone"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Mofebutazon"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AA",
"display": "Butylpyrazolidines"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AA02",
"display": "M01AA02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AA02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AE12",
"display": "Oxaprozin",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Oxaprozin"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Oksaprozin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AE",
"display": "Propionic acid derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AE12",
"display": "M01AE12"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AE12"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M03BX",
"display": "Other centrally acting agents",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Other centrally acting agents"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Andre sentralt virkende midler"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M03B",
"display": "Muscle relaxants, centrally acting agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M03BX",
"display": "M03BX"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M03BX"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M02AA05",
"display": "Benzydamine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Benzydamine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Benzydamin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M02AA",
"display": "Antiinflammatory preparations, non-steroids for topical use"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M02AA05",
"display": "M02AA05"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M02AA05"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01CX",
"display": "Other specific antirheumatic agents",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Other specific antirheumatic agents"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Andre spesifikke antireumatiske midler"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01C",
"display": "Spesific antirheumatic agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01CX",
"display": "M01CX"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01CX"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AX25",
"display": "Chondroitin sulfate",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Chondroitin sulfate"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Kondroitinsulfat"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AX",
"display": "Other antiinflammatory and antirheumatic agents, non-steroids"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AX25",
"display": "M01AX25"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2007-03-04T00:00:00Z",
"display": "2007-03-04T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AX25"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AC06",
"display": "Meloxicam",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Meloxicam"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Meloksikam"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AC",
"display": "Oxicams"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AC06",
"display": "M01AC06"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AC06"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AH07",
"display": "Polmacoxib",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Polmacoxib"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Polmakoksib"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AH",
"display": "Coxibs"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AH07",
"display": "M01AH07"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2017-12-01T00:00:00Z",
"display": "2017-12-01T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AH07"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M02AA19",
"display": "Flurbiprofen",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Flurbiprofen"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Flurbiprofen"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M02AA",
"display": "Antiinflammatory preparations, non-steroids for topical use"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M02AA19",
"display": "M02AA19"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M02AA19"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AB01",
"display": "Indometacin",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Indometacin"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Indometacin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AB",
"display": "Acetic acid derivatives and related substances"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AB01",
"display": "M01AB01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AB01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M02AA",
"display": "Antiinflammatory preparations, non-steroids for topical use",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Antiinflammatory preparations, non-steroids for topical use"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Ikke-steroide antiinflammatoriske midler til topikal bruk"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M02A",
"display": "Topical products for joint and muscular pain"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M02AA",
"display": "M02AA"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M02AA"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M05BA07",
"display": "Risedronic acid",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Risedronic acid"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Risedronsyre"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M05BA",
"display": "Bisphosphonates"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M05BA07",
"display": "M05BA07"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M05BA07"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M09AX13",
"display": "Casimersen",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Casimersen"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Kasimersen"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M09AX",
"display": "Other drugs for disorders of the musculo-skeletal system"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M09AX13",
"display": "M09AX13"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2021-11-08T00:00:00Z",
"display": "2021-11-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M09AX13"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AX04",
"display": "Azapropazone",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Azapropazone"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Azapropazon"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AX",
"display": "Other antiinflammatory and antirheumatic agents, non-steroids"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AX04",
"display": "M01AX04"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AX04"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01",
"display": "Antiinflammatory and antirheumatic products",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Antiinflammatory and antirheumatic products"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Antiinflammatoriske og antireumatiske midler"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M",
"display": "Musculo-skeletal system"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01",
"display": "M01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M02AA01",
"display": "Phenylbutazone",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Phenylbutazone"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Fenylbutazon"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M02AA",
"display": "Antiinflammatory preparations, non-steroids for topical use"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M02AA01",
"display": "M02AA01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M02AA01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M03BB52",
"display": "Chlormezanone, combinations excl. psycholeptics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Chlormezanone, combinations excl. psycholeptics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Klormezanon, kombinasjoner ekskl. psykoleptika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M03BB",
"display": "Oxazol, thiazine, and triazine derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M03BB52",
"display": "M03BB52"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M03BB52"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M03BX53",
"display": "Pridinol, combinations",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Pridinol, combinations"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Pridinol, kombinasjoner"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M03BX",
"display": "Other centrally acting agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M03BX53",
"display": "M03BX53"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2022-05-06T00:00:00Z",
"display": "2022-05-06T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M03BX53"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M03BA53",
"display": "Methocarbamol, combinations excl. psycholeptics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Methocarbamol, combinations excl. psycholeptics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Metokarbamol, kombinasjoner ekskl. psykoleptika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M03BA",
"display": "Carbamic acid esters"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M03BA53",
"display": "M03BA53"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M03BA53"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M02AC",
"display": "Preparations with salicylic acid derivatives",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Preparations with salicylic acid derivatives"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Midler med innhold av salisyrederivater"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M02A",
"display": "Topical products for joint and muscular pain"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M02AC",
"display": "M02AC"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M02AC"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AA01",
"display": "Phenylbutazone",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Phenylbutazone"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Fenylbutazon"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AA",
"display": "Butylpyrazolidines"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AA01",
"display": "M01AA01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AA01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M05B",
"display": "Drugs affecting bone structure and mineralization",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Drugs affecting bone structure and mineralization"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Midler med effekt på benstruktur og mineralisering"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M05",
"display": "Drugs for treatment of bone diseases"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M05B",
"display": "M05B"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M05B"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M09AX15",
"display": "Delandistrogene moxeparvovec",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Delandistrogene moxeparvovec"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Delandistrogenmokseparvovek"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M09AX",
"display": "Other drugs for disorders of the musculo-skeletal system"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M09AX15",
"display": "M09AX15"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2023-11-15T00:00:00Z",
"display": "2023-11-15T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M09AX15"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M02AB01",
"display": "Capsaicin",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Capsaicin"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Capsaicin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M02AB",
"display": "Capsaicin and similar agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M02AB01",
"display": "M02AB01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2008-12-29T00:00:00Z",
"display": "2008-12-29T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M02AB01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01CB",
"display": "Gold preparations",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Gold preparations"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Gullmidler"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01C",
"display": "Spesific antirheumatic agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01CB",
"display": "M01CB"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01CB"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M03BA05",
"display": "Febarbamate",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Febarbamate"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Febarbamat"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M03BA",
"display": "Carbamic acid esters"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M03BA05",
"display": "M03BA05"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M03BA05"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01CA",
"display": "Quinolines",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Quinolines"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Kinolinderivater"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01C",
"display": "Spesific antirheumatic agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01CA",
"display": "M01CA"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01CA"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M09AB52",
"display": "Trypsin, combinations",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Trypsin, combinations"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Trypsin, kombinasjoner"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M09AB",
"display": "Enzymes"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M09AB52",
"display": "M09AB52"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M09AB52"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AX21",
"display": "Diacerein",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Diacerein"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Diacerein"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AX",
"display": "Other antiinflammatory and antirheumatic agents, non-steroids"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AX21",
"display": "M01AX21"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AX21"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M03AC08",
"display": "Fazadinium bromide",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Fazadinium bromide"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Fazadiniumbromid"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M03AC",
"display": "Other quaternary ammonium compounds"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M03AC08",
"display": "M03AC08"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M03AC08"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M09AX09",
"display": "Onasemnogene abeparvovec",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Onasemnogene abeparvovec"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Onasemnogenabeparvovek"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M09AX",
"display": "Other drugs for disorders of the musculo-skeletal system"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M09AX09",
"display": "M09AX09"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2020-05-20T00:00:00Z",
"display": "2020-05-20T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M09AX09"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AG",
"display": "Fenamates",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Fenamates"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Fenamater"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01A",
"display": "Antiinflammatory and antirheumatic products, non-steroids"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AG",
"display": "M01AG"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AG"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01BA02",
"display": "Dipyrocetyl and corticosteroids",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Dipyrocetyl and corticosteroids"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Dipyrocetyl og kortikosteroider"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01BA",
"display": "Antiinflammatory/antirheumatic agents in combination with corticosteroids"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01BA02",
"display": "M01BA02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01BA02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M03AC04",
"display": "Atracurium",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Atracurium"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Atrakurium"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M03AC",
"display": "Other quaternary ammonium compounds"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M03AC04",
"display": "M03AC04"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M03AC04"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M03A",
"display": "Muscle relaxants, peripherally acting agents",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Muscle relaxants, peripherally acting agents"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Perifert virkende muskelrelakserende midler"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M03",
"display": "Muscle relaxants"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M03A",
"display": "M03A"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M03A"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M03BX07",
"display": "Tetrazepam",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Tetrazepam"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Tetrazepam"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M03BX",
"display": "Other centrally acting agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M03BX07",
"display": "M03BX07"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M03BX07"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M05BB",
"display": "Bisphosphonates, combinations",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Bisphosphonates, combinations"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Bisfosfonater, kombinasjoner"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M05B",
"display": "Drugs affecting bone structure and mineralization"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M05BB",
"display": "M05BB"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M05BB"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AB13",
"display": "Oxametacin",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Oxametacin"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Oksametacin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AB",
"display": "Acetic acid derivatives and related substances"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AB13",
"display": "M01AB13"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AB13"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M05BB07",
"display": "Risedronic acid and colecalciferol",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Risedronic acid and colecalciferol"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Risedronsyre og kolekalsiferol"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M05BB",
"display": "Bisphosphonates, combinations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M05BB07",
"display": "M05BB07"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2014-02-20T00:00:00Z",
"display": "2014-02-20T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M05BB07"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M05BB09",
"display": "Ibandronic acid and colecalciferol",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Ibandronic acid and colecalciferol"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Ibandronsyre og kolekalsiferol"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M05BB",
"display": "Bisphosphonates, combinations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M05BB09",
"display": "M05BB09"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2018-07-11T00:00:00Z",
"display": "2018-07-11T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M05BB09"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M04AA03",
"display": "Febuxostat",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Febuxostat"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Febuksostat"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M04AA",
"display": "Preparations inhibiting uric acid production"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M04AA03",
"display": "M04AA03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2007-03-04T00:00:00Z",
"display": "2007-03-04T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M04AA03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M04AC02",
"display": "Cinchophen",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Cinchophen"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Cinkofen"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M04AC",
"display": "Preparations with no effect on uric acid metabolism"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M04AC02",
"display": "M04AC02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M04AC02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M02AX02",
"display": "Tolazoline",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Tolazoline"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Tolazolin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M02AX",
"display": "Other topical products for joint and muscular pain"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M02AX02",
"display": "M02AX02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M02AX02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M03AA",
"display": "Curare alkaloids",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Curare alkaloids"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Kurarealkaloider"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M03A",
"display": "Muscle relaxants, peripherally acting agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M03AA",
"display": "M03AA"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M03AA"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M04AA51",
"display": "Allopurinol, combinations",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Allopurinol, combinations"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Allopurinol, kombinasjoner"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M04AA",
"display": "Preparations inhibiting uric acid production"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M04AA51",
"display": "M04AA51"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M04AA51"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M03BC51",
"display": "Orphenadrine, combinations",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Orphenadrine, combinations"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Orfenadrin, kombinasjoner"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M03BC",
"display": "Ethers, chemically close to antihistamines"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M03BC51",
"display": "M03BC51"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M03BC51"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M05BB04",
"display": "Risedronic acid, calcium and colecalciferol, sequential",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Risedronic acid, calcium and colecalciferol, sequential"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Risedronsyre, kalsium og kolekalsiferol, sekvensielle"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M05BB",
"display": "Bisphosphonates, combinations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M05BB04",
"display": "M05BB04"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2008-01-01T00:00:00Z",
"display": "2008-01-01T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M05BB04"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M02A",
"display": "Topical products for joint and muscular pain",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Topical products for joint and muscular pain"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Topikale midler ved muskel- og leddsmerter"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M02",
"display": "Topical products for joint and muscular pain"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M02A",
"display": "M02A"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M02A"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M03BA02",
"display": "Carisoprodol",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Carisoprodol"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Karisoprodol"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M03BA",
"display": "Carbamic acid esters"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M03BA02",
"display": "M03BA02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M03BA02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M03AC07",
"display": "Doxacurium chloride",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Doxacurium chloride"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Doksakuriumklorid"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M03AC",
"display": "Other quaternary ammonium compounds"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M03AC07",
"display": "M03AC07"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M03AC07"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M02AX05",
"display": "Idrocilamide",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Idrocilamide"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Idrocilamid"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M02AX",
"display": "Other topical products for joint and muscular pain"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M02AX05",
"display": "M02AX05"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2011-01-01T00:00:00Z",
"display": "2011-01-01T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M02AX05"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AX07",
"display": "Benzydamine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Benzydamine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Benzydamin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AX",
"display": "Other antiinflammatory and antirheumatic agents, non-steroids"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AX07",
"display": "M01AX07"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AX07"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01CB05",
"display": "Aurotioprol",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Aurotioprol"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Aurotioprol"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01CB",
"display": "Gold preparations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01CB05",
"display": "M01CB05"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01CB05"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AC56",
"display": "Meloxicam, combinations",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Meloxicam, combinations"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Meloksikam, kombinasjoner"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AC",
"display": "Oxicams"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AC56",
"display": "M01AC56"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2012-01-01T00:00:00Z",
"display": "2012-01-01T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AC56"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AE15",
"display": "Flunoxaprofen",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Flunoxaprofen"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Flunoksaprofen"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AE",
"display": "Propionic acid derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AE15",
"display": "M01AE15"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AE15"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AE52",
"display": "Naproxen and esomeprazole",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Naproxen and esomeprazole"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Naproksen og esomeprazol"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AE",
"display": "Propionic acid derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AE52",
"display": "M01AE52"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2009-10-15T00:00:00Z",
"display": "2009-10-15T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AE52"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AB55",
"display": "Diclofenac, combinations",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Diclofenac, combinations"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Diklofenak, kombinasjoner"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AB",
"display": "Acetic acid derivatives and related substances"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AB55",
"display": "M01AB55"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AB55"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AX01",
"display": "Nabumetone",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Nabumetone"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Nabumeton"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AX",
"display": "Other antiinflammatory and antirheumatic agents, non-steroids"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AX01",
"display": "M01AX01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AX01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AC04",
"display": "Droxicam",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Droxicam"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Droksikam"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AC",
"display": "Oxicams"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AC04",
"display": "M01AC04"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AC04"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M05BA02",
"display": "Clodronic acid",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Clodronic acid"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Klodronsyre"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M05BA",
"display": "Bisphosphonates"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M05BA02",
"display": "M05BA02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M05BA02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M03AC09",
"display": "Rocuronium bromide",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Rocuronium bromide"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Rokuroniumbromid"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M03AC",
"display": "Other quaternary ammonium compounds"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M03AC09",
"display": "M03AC09"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M03AC09"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M03BB53",
"display": "Chlorzoxazone, combinations excl. psycholeptics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Chlorzoxazone, combinations excl. psycholeptics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Klorzoksason, kombinasjoner ekskl. psykoleptika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M03BB",
"display": "Oxazol, thiazine, and triazine derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M03BB53",
"display": "M03BB53"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M03BB53"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M09AX14",
"display": "Givinostat",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Givinostat"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Givinostat"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M09AX",
"display": "Other drugs for disorders of the musculo-skeletal system"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M09AX14",
"display": "M09AX14"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2023-12-05T00:00:00Z",
"display": "2023-12-05T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M09AX14"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M04AA02",
"display": "Tisopurine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Tisopurine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Tisopurin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M04AA",
"display": "Preparations inhibiting uric acid production"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M04AA02",
"display": "M04AA02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M04AA02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AE",
"display": "Propionic acid derivatives",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Propionic acid derivatives"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Propionsyrederivater"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01A",
"display": "Antiinflammatory and antirheumatic products, non-steroids"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AE",
"display": "M01AE"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AE"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M03BA51",
"display": "Phenprobamate, combinations excl. psycholeptics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Phenprobamate, combinations excl. psycholeptics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Fenprobamat, kombinasjoner ekskl. psykoleptika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M03BA",
"display": "Carbamic acid esters"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M03BA51",
"display": "M03BA51"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M03BA51"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M09",
"display": "Other drugs for disorders of the musculo-skeletal system",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Other drugs for disorders of the musculo-skeletal system"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Andre midler mot muskel- og skjelettsykdommer"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M",
"display": "Musculo-skeletal system"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M09",
"display": "M09"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M09"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M02AA11",
"display": "Bendazac",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Bendazac"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Bendazak"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M02AA",
"display": "Antiinflammatory preparations, non-steroids for topical use"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M02AA11",
"display": "M02AA11"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M02AA11"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M05BA04",
"display": "Alendronic acid",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Alendronic acid"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Alendronsyre"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M05BA",
"display": "Bisphosphonates"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M05BA04",
"display": "M05BA04"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M05BA04"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AH03",
"display": "Valdecoxib",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Valdecoxib"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Valdekoksib"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AH",
"display": "Coxibs"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AH03",
"display": "M01AH03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2003-05-07T00:00:00Z",
"display": "2003-05-07T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AH03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M02AA13",
"display": "Ibuprofen",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Ibuprofen"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Ibuprofen"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M02AA",
"display": "Antiinflammatory preparations, non-steroids for topical use"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M02AA13",
"display": "M02AA13"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M02AA13"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M09AX02",
"display": "Chondrocytes, autologous",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Chondrocytes, autologous"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Kondrocytter, autologe"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M09AX",
"display": "Other drugs for disorders of the musculo-skeletal system"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M09AX02",
"display": "M09AX02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2011-01-01T00:00:00Z",
"display": "2011-01-01T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M09AX02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M09AX01",
"display": "Hyaluronic acid",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Hyaluronic acid"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Hyaluronsyre"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M09AX",
"display": "Other drugs for disorders of the musculo-skeletal system"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M09AX01",
"display": "M09AX01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M09AX01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M02AA12",
"display": "Naproxen",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Naproxen"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Naproksen"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M02AA",
"display": "Antiinflammatory preparations, non-steroids for topical use"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M02AA12",
"display": "M02AA12"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M02AA12"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01B",
"display": "Antiinflammatory/antirheumatic agents in combination",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Antiinflammatory/antirheumatic agents in combination"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Antiinflammatoriske og antireumatiske midler i kombinasjon"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01",
"display": "Antiinflammatory and antirheumatic products"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01B",
"display": "M01B"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01B"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M02AA28",
"display": "Piketoprofen",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Piketoprofen"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Piketoprofen"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M02AA",
"display": "Antiinflammatory preparations, non-steroids for topical use"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M02AA28",
"display": "M02AA28"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2016-12-21T00:00:00Z",
"display": "2016-12-21T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M02AA28"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M02AA24",
"display": "Nifenazone",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Nifenazone"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Nifenazon"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M02AA",
"display": "Antiinflammatory preparations, non-steroids for topical use"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M02AA24",
"display": "M02AA24"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2007-03-04T00:00:00Z",
"display": "2007-03-04T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M02AA24"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AX22",
"display": "Morniflumate",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Morniflumate"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Morniflumat"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AX",
"display": "Other antiinflammatory and antirheumatic agents, non-steroids"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AX22",
"display": "M01AX22"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AX22"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AX13",
"display": "Proquazone",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Proquazone"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Prokvazon"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AX",
"display": "Other antiinflammatory and antirheumatic agents, non-steroids"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AX13",
"display": "M01AX13"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AX13"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M03BA03",
"display": "Methocarbamol",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Methocarbamol"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Metokarbamol"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M03BA",
"display": "Carbamic acid esters"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M03BA03",
"display": "M03BA03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M03BA03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M03BX01",
"display": "Baclofen",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Baclofen"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Baklofen"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M03BX",
"display": "Other centrally acting agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M03BX01",
"display": "M03BX01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M03BX01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AX",
"display": "Other antiinflammatory and antirheumatic agents, non-steroids",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Other antiinflammatory and antirheumatic agents, non-steroids"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Andre antiinflammatoriske og antireumatiske midler, ikke-steroider"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01A",
"display": "Antiinflammatory and antirheumatic products, non-steroids"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AX",
"display": "M01AX"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AX"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M05BB02",
"display": "Risedronic acid and calcium, sequential",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Risedronic acid and calcium, sequential"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Risedronsyre og kalsium, sekvensielle"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M05BB",
"display": "Bisphosphonates, combinations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M05BB02",
"display": "M05BB02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2007-01-01T00:00:00Z",
"display": "2007-01-01T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M05BB02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AE14",
"display": "Dexibuprofen",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Dexibuprofen"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Deksibuprofen"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AE",
"display": "Propionic acid derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AE14",
"display": "M01AE14"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AE14"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AG02",
"display": "Tolfenamic acid",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Tolfenamic acid"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Tolfenamsyre"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AG",
"display": "Fenamates"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AG02",
"display": "M01AG02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AG02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AE11",
"display": "Tiaprofenic acid",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Tiaprofenic acid"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Tiaprofensyre"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AE",
"display": "Propionic acid derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AE11",
"display": "M01AE11"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AE11"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AA",
"display": "Butylpyrazolidines",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Butylpyrazolidines"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Butylpyrazolidiner"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01A",
"display": "Antiinflammatory and antirheumatic products, non-steroids"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AA",
"display": "M01AA"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AA"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M02AA16",
"display": "Feprazone",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Feprazone"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Feprazon"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M02AA",
"display": "Antiinflammatory preparations, non-steroids for topical use"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M02AA16",
"display": "M02AA16"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M02AA16"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M05BA08",
"display": "Zoledronic acid",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Zoledronic acid"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Zoledronsyre"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M05BA",
"display": "Bisphosphonates"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M05BA08",
"display": "M05BA08"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2003-06-19T00:00:00Z",
"display": "2003-06-19T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M05BA08"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AB09",
"display": "Lonazolac",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Lonazolac"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Lonazolak"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AB",
"display": "Acetic acid derivatives and related substances"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AB09",
"display": "M01AB09"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AB09"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M02AX03",
"display": "Dimethyl sulfoxide",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Dimethyl sulfoxide"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Dimetylsulfoksid"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M02AX",
"display": "Other topical products for joint and muscular pain"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M02AX03",
"display": "M02AX03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M02AX03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AE20",
"display": "Pelubiprofen",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Pelubiprofen"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Pelubiprofen"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AE",
"display": "Propionic acid derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AE20",
"display": "M01AE20"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2024-11-19T00:00:00Z",
"display": "2024-11-19T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AE20"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M05BX06",
"display": "Romosozumab",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Romosozumab"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Romosozumab"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M05BX",
"display": "Other drugs affecting bone structure and mineralization"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M05BX06",
"display": "M05BX06"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2017-01-11T00:00:00Z",
"display": "2017-01-11T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M05BX06"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M05BB06",
"display": "Alendronic acid and alfacalcidol, sequential",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Alendronic acid and alfacalcidol, sequential"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Alendronsyre og kolekalsiferol, sekvensielle"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M05BB",
"display": "Bisphosphonates, combinations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M05BB06",
"display": "M05BB06"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2013-01-29T00:00:00Z",
"display": "2013-01-29T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M05BB06"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AE16",
"display": "Alminoprofen",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Alminoprofen"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Alminoprofen"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AE",
"display": "Propionic acid derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AE16",
"display": "M01AE16"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AE16"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AB15",
"display": "Ketorolac",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Ketorolac"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Ketorolak"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AB",
"display": "Acetic acid derivatives and related substances"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AB15",
"display": "M01AB15"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AB15"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M09AX11",
"display": "Palovarotene",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Palovarotene"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Palovaroten"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M09AX",
"display": "Other drugs for disorders of the musculo-skeletal system"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M09AX11",
"display": "M09AX11"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2020-11-11T00:00:00Z",
"display": "2020-11-11T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M09AX11"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M03BX04",
"display": "Tolperisone",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Tolperisone"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Tolperison"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M03BX",
"display": "Other centrally acting agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M03BX04",
"display": "M03BX04"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M03BX04"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AX05",
"display": "Glucosamine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Glucosamine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Glukosamin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AX",
"display": "Other antiinflammatory and antirheumatic agents, non-steroids"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AX05",
"display": "M01AX05"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AX05"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M02",
"display": "Topical products for joint and muscular pain",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Topical products for joint and muscular pain"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Topikale midler ved muskel- og leddsmerter"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M",
"display": "Musculo-skeletal system"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M02",
"display": "M02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AX17",
"display": "Nimesulide",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Nimesulide"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Nimesulid"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AX",
"display": "Other antiinflammatory and antirheumatic agents, non-steroids"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AX17",
"display": "M01AX17"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AX17"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AB10",
"display": "Fentiazac",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Fentiazac"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Fentiazak"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AB",
"display": "Acetic acid derivatives and related substances"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AB10",
"display": "M01AB10"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AB10"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M09AA",
"display": "Quinine and derivatives",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Quinine and derivatives"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Kinin og derivater"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M09A",
"display": "Other drugs for disorders of the musculo-skeletal system"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M09AA",
"display": "M09AA"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M09AA"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M04A",
"display": "Antigout preparations",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Antigout preparations"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Giktmidler"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M04",
"display": "Antigout preparations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M04A",
"display": "M04A"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M04A"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M03B",
"display": "Muscle relaxants, centrally acting agents",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Muscle relaxants, centrally acting agents"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Sentralt virkende muskelrelakserende midler"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M03",
"display": "Muscle relaxants"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M03B",
"display": "M03B"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M03B"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M03",
"display": "Muscle relaxants",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Muscle relaxants"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Muskelrelakserende midler"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M",
"display": "Musculo-skeletal system"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M03",
"display": "M03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M03BX30",
"display": "Fenyramidol",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Fenyramidol"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Fenyramidol"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M03BX",
"display": "Other centrally acting agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M03BX30",
"display": "M03BX30"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M03BX30"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M03AB",
"display": "Choline derivatives",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Choline derivatives"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Kolinderivater"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M03A",
"display": "Muscle relaxants, peripherally acting agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M03AB",
"display": "M03AB"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M03AB"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01CA03",
"display": "Oxycinchophen",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Oxycinchophen"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Oksycinkofen"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01CA",
"display": "Quinolines"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01CA03",
"display": "M01CA03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01CA03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AB02",
"display": "Sulindac",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Sulindac"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Sulindak"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AB",
"display": "Acetic acid derivatives and related substances"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AB02",
"display": "M01AB02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AB02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M05BA05",
"display": "Tiludronic acid",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Tiludronic acid"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Tiludronsyre"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M05BA",
"display": "Bisphosphonates"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M05BA05",
"display": "M05BA05"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M05BA05"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M05BB08",
"display": "Zoledronic acid, calcium and colecalciferol, sequential",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Zoledronic acid, calcium and colecalciferol, sequential"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Zoledronsyre, kalsium og kolekalsiferol, sekvensielle"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M05BB",
"display": "Bisphosphonates, combinations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M05BB08",
"display": "M05BB08"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2015-07-06T00:00:00Z",
"display": "2015-07-06T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M05BB08"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AG01",
"display": "Mefenamic acid",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Mefenamic acid"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Mefenamsyre"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AG",
"display": "Fenamates"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AG01",
"display": "M01AG01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AG01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M03BA01",
"display": "Phenprobamate",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Phenprobamate"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Fenprobamat"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M03BA",
"display": "Carbamic acid esters"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M03BA01",
"display": "M03BA01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M03BA01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01C",
"display": "Spesific antirheumatic agents",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Spesific antirheumatic agents"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Spesifikke antireumatiske midler"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01",
"display": "Antiinflammatory and antirheumatic products"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01C",
"display": "M01C"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01C"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M05BC02",
"display": "Eptotermin alfa",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Eptotermin alfa"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Eptotermin alfa"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M05BC",
"display": "Bone morphogenetic proteins"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M05BC02",
"display": "M05BC02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2003-09-24T00:00:00Z",
"display": "2003-09-24T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M05BC02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M09AX07",
"display": "Nusinersen",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Nusinersen"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Nusinersen"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M09AX",
"display": "Other drugs for disorders of the musculo-skeletal system"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M09AX07",
"display": "M09AX07"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2017-05-02T00:00:00Z",
"display": "2017-05-02T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M09AX07"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AA05",
"display": "Clofezone",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Clofezone"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Klofezon"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AA",
"display": "Butylpyrazolidines"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AA05",
"display": "M01AA05"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AA05"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M02AA08",
"display": "Felbinac",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Felbinac"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Felbinak"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M02AA",
"display": "Antiinflammatory preparations, non-steroids for topical use"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M02AA08",
"display": "M02AA08"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M02AA08"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AE06",
"display": "Benoxaprofen",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Benoxaprofen"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Benoksaprofen"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AE",
"display": "Propionic acid derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AE06",
"display": "M01AE06"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AE06"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M03AC",
"display": "Other quaternary ammonium compounds",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Other quaternary ammonium compounds"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Andre kvartære ammoniumforbindelser"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M03A",
"display": "Muscle relaxants, peripherally acting agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M03AC",
"display": "M03AC"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M03AC"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AB16",
"display": "Aceclofenac",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Aceclofenac"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Aceklofenak"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AB",
"display": "Acetic acid derivatives and related substances"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AB16",
"display": "M01AB16"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AB16"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M03AX",
"display": "Other muscle relaxants, peripherally acting agents",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Other muscle relaxants, peripherally acting agents"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Andre perifert virkende muskelrelakserende midler"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M03A",
"display": "Muscle relaxants, peripherally acting agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M03AX",
"display": "M03AX"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M03AX"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M05BA06",
"display": "Ibandronic acid",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Ibandronic acid"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Ibandronsyre"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M05BA",
"display": "Bisphosphonates"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M05BA06",
"display": "M05BA06"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M05BA06"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M09A",
"display": "Other drugs for disorders of the musculo-skeletal system",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Other drugs for disorders of the musculo-skeletal system"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Andre midler mot muskel- og skjelettsykdommer"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M09",
"display": "Other drugs for disorders of the musculo-skeletal system"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M09A",
"display": "M09A"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M09A"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M05BX08",
"display": "Menatetrenone",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Menatetrenone"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Menatetrenon"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M05BX",
"display": "Other drugs affecting bone structure and mineralization"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M05BX08",
"display": "M05BX08"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2022-05-06T00:00:00Z",
"display": "2022-05-06T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M05BX08"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01BA03",
"display": "Acetylsalicylic acid and corticosteroids",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Acetylsalicylic acid and corticosteroids"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Acetylsalisylsyre og kortikosteroider"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01BA",
"display": "Antiinflammatory/antirheumatic agents in combination with corticosteroids"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01BA03",
"display": "M01BA03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01BA03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M09AB03",
"display": "Bromelains",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Bromelains"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Bromelener"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M09AB",
"display": "Enzymes"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M09AB03",
"display": "M09AB03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2014-02-20T00:00:00Z",
"display": "2014-02-20T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M09AB03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M02AX",
"display": "Other topical products for joint and muscular pain",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Other topical products for joint and muscular pain"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Andre topikale midler ved muskel- og leddsmerter"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M02A",
"display": "Topical products for joint and muscular pain"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M02AX",
"display": "M02AX"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M02AX"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AE09",
"display": "Flurbiprofen",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Flurbiprofen"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Flurbiprofen"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AE",
"display": "Propionic acid derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AE09",
"display": "M01AE09"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AE09"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M04",
"display": "Antigout preparations",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Antigout preparations"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Giktmidler"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M",
"display": "Musculo-skeletal system"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M04",
"display": "M04"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M04"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M04AX01",
"display": "Urate oxidase",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Urate oxidase"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Uratoksidase"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M04AX",
"display": "Other antigout preparations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M04AX01",
"display": "M04AX01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M04AX01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M02AA14",
"display": "Fentiazac",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Fentiazac"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Fentiazak"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M02AA",
"display": "Antiinflammatory preparations, non-steroids for topical use"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M02AA14",
"display": "M02AA14"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M02AA14"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AH01",
"display": "Celecoxib",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Celecoxib"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Celekoksib"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AH",
"display": "Coxibs"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AH01",
"display": "M01AH01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AH01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M03BX08",
"display": "Cyclobenzaprine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Cyclobenzaprine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Cyklobenzaprin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M03BX",
"display": "Other centrally acting agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M03BX08",
"display": "M03BX08"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M03BX08"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M03AB01",
"display": "Suxamethonium",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Suxamethonium"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Suksametonium"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M03AB",
"display": "Choline derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M03AB01",
"display": "M03AB01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M03AB01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M02AA10",
"display": "Ketoprofen",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Ketoprofen"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Ketoprofen"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M02AA",
"display": "Antiinflammatory preparations, non-steroids for topical use"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M02AA10",
"display": "M02AA10"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M02AA10"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AC01",
"display": "Piroxicam",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Piroxicam"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Piroksikam"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AC",
"display": "Oxicams"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AC01",
"display": "M01AC01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AC01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AE07",
"display": "Suprofen",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Suprofen"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Suprofen"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AE",
"display": "Propionic acid derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AE07",
"display": "M01AE07"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AE07"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AH",
"display": "Coxibs",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Coxibs"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Koksiber"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01A",
"display": "Antiinflammatory and antirheumatic products, non-steroids"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AH",
"display": "M01AH"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AH"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M05BX05",
"display": "Burosumab",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Burosumab"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Burosumab"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M05BX",
"display": "Other drugs affecting bone structure and mineralization"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M05BX05",
"display": "M05BX05"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2016-12-21T00:00:00Z",
"display": "2016-12-21T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M05BX05"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M05BB05",
"display": "Alendronic acid, calcium and colecalciferol, sequential",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Alendronic acid, calcium and colecalciferol, sequential"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Alendronsyre, kalsium og kolekalsiferol, sekvensielle"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M05BB",
"display": "Bisphosphonates, combinations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M05BB05",
"display": "M05BB05"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2011-01-01T00:00:00Z",
"display": "2011-01-01T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M05BB05"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AC",
"display": "Oxicams",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Oxicams"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Oksikamer"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01A",
"display": "Antiinflammatory and antirheumatic products, non-steroids"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AC",
"display": "M01AC"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AC"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M09AX08",
"display": "Golodirsen",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Golodirsen"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Golodirsen"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M09AX",
"display": "Other drugs for disorders of the musculo-skeletal system"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M09AX08",
"display": "M09AX08"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2020-11-11T00:00:00Z",
"display": "2020-11-11T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M09AX08"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M03AC01",
"display": "Pancuronium",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Pancuronium"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Pankuronium"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M03AC",
"display": "Other quaternary ammonium compounds"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M03AC01",
"display": "M03AC01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M03AC01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01CC",
"display": "Penicillamine and similar agents",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Penicillamine and similar agents"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Penicillamin og lignende substanser"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01C",
"display": "Spesific antirheumatic agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01CC",
"display": "M01CC"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01CC"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M02AA06",
"display": "Etofenamate",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Etofenamate"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Etofenamat"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M02AA",
"display": "Antiinflammatory preparations, non-steroids for topical use"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M02AA06",
"display": "M02AA06"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M02AA06"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M02AA02",
"display": "Mofebutazone",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Mofebutazone"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Mofebutazon"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M02AA",
"display": "Antiinflammatory preparations, non-steroids for topical use"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M02AA02",
"display": "M02AA02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M02AA02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M03BA",
"display": "Carbamic acid esters",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Carbamic acid esters"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Karbaminsyreestre"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M03B",
"display": "Muscle relaxants, centrally acting agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M03BA",
"display": "M03BA"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M03BA"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M04AC",
"display": "Preparations with no effect on uric acid metabolism",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Preparations with no effect on uric acid metabolism"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Midler uten virkning på urinsyreomsetningen"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M04A",
"display": "Antigout preparations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M04AC",
"display": "M04AC"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M04AC"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M02AA21",
"display": "Tolmetin",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Tolmetin"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Tolmetin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M02AA",
"display": "Antiinflammatory preparations, non-steroids for topical use"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M02AA21",
"display": "M02AA21"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M02AA21"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01BX",
"display": "Other antiinflammatory/antirheumatic agents in combination with other drugs",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Other antiinflammatory/antirheumatic agents in combination with other drugs"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Andre antiinflammatoriske/antireumatiske midler i kombinasjon med andre midler"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01B",
"display": "Antiinflammatory/antirheumatic agents in combination"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01BX",
"display": "M01BX"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01BX"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AH05",
"display": "Etoricoxib",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Etoricoxib"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Etorikoksib"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AH",
"display": "Coxibs"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AH05",
"display": "M01AH05"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2003-03-31T00:00:00Z",
"display": "2003-03-31T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AH05"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M03BA71",
"display": "Phenprobamate, combinations with psycholeptics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Phenprobamate, combinations with psycholeptics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Fenprobamat, kombinasjoner med psykoleptika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M03BA",
"display": "Carbamic acid esters"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M03BA71",
"display": "M03BA71"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M03BA71"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M02AA22",
"display": "Suxibuzone",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Suxibuzone"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Suksibuzon"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M02AA",
"display": "Antiinflammatory preparations, non-steroids for topical use"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M02AA22",
"display": "M02AA22"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M02AA22"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M03AC05",
"display": "Hexafluronium",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Hexafluronium"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Heksafluronium"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M03AC",
"display": "Other quaternary ammonium compounds"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M03AC05",
"display": "M03AC05"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M03AC05"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M05",
"display": "Drugs for treatment of bone diseases",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Drugs for treatment of bone diseases"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Midler til behandling av bensykdommer"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M",
"display": "Musculo-skeletal system"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M05",
"display": "M05"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M05"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M03BB03",
"display": "Chlorzoxazone",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Chlorzoxazone"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Klorzoksason"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M03BB",
"display": "Oxazol, thiazine, and triazine derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M03BB03",
"display": "M03BB03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M03BB03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M05BC",
"display": "Bone morphogenetic proteins",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Bone morphogenetic proteins"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Beninduserende proteiner"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M05B",
"display": "Drugs affecting bone structure and mineralization"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M05BC",
"display": "M05BC"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2007-03-04T00:00:00Z",
"display": "2007-03-04T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M05BC"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M04AX02",
"display": "Pegloticase",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Pegloticase"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Peglotikase"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M04AX",
"display": "Other antigout preparations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M04AX02",
"display": "M04AX02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2010-01-01T00:00:00Z",
"display": "2010-01-01T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M04AX02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AH06",
"display": "Lumiracoxib",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Lumiracoxib"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Lumirakoksib"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AH",
"display": "Coxibs"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AH06",
"display": "M01AH06"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2004-08-16T00:00:00Z",
"display": "2004-08-16T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AH06"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AB12",
"display": "Difenpiramide",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Difenpiramide"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Difenpiramid"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AB",
"display": "Acetic acid derivatives and related substances"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AB12",
"display": "M01AB12"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AB12"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M02AA26",
"display": "Nimesulide",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Nimesulide"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Nimesulid"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M02AA",
"display": "Antiinflammatory preparations, non-steroids for topical use"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M02AA26",
"display": "M02AA26"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2011-01-01T00:00:00Z",
"display": "2011-01-01T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M02AA26"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AE18",
"display": "Naproxcinod",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Naproxcinod"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Naprokscinod"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AE",
"display": "Propionic acid derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AE18",
"display": "M01AE18"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2011-01-01T00:00:00Z",
"display": "2011-01-01T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AE18"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AE03",
"display": "Ketoprofen",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Ketoprofen"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Ketoprofen"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AE",
"display": "Propionic acid derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AE03",
"display": "M01AE03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AE03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M05BA03",
"display": "Pamidronic acid",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Pamidronic acid"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Pamidronsyre"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M05BA",
"display": "Bisphosphonates"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M05BA03",
"display": "M05BA03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M05BA03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M03BX09",
"display": "Eperisone",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Eperisone"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Eperison"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M03BX",
"display": "Other centrally acting agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M03BX09",
"display": "M03BX09"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2010-01-01T00:00:00Z",
"display": "2010-01-01T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M03BX09"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AX24",
"display": "Oxaceprol",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Oxaceprol"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Oksaceprol"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AX",
"display": "Other antiinflammatory and antirheumatic agents, non-steroids"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AX24",
"display": "M01AX24"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AX24"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AH04",
"display": "Parecoxib",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Parecoxib"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Parekoksib"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AH",
"display": "Coxibs"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AH04",
"display": "M01AH04"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2006-05-30T00:00:00Z",
"display": "2006-05-30T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AH04"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M03CA",
"display": "Dantrolene and derivatives",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Dantrolene and derivatives"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Dantrolen og derivater"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M03C",
"display": "Muscle relaxants, directly acting agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M03CA",
"display": "M03CA"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M03CA"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M03C",
"display": "Muscle relaxants, directly acting agents",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Muscle relaxants, directly acting agents"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Direkte virkende muskelrelakserende midler"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M03",
"display": "Muscle relaxants"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M03C",
"display": "M03C"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M03C"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M03AX01",
"display": "Botulinum toxin",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Botulinum toxin"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Botulinumtoksin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M03AX",
"display": "Other muscle relaxants, peripherally acting agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M03AX01",
"display": "M03AX01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M03AX01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M09AA01",
"display": "Hydroquinine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Hydroquinine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Hydrokinin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M09AA",
"display": "Quinine and derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M09AA01",
"display": "M09AA01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M09AA01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01BA01",
"display": "Phenylbutazone and corticosteroids",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Phenylbutazone and corticosteroids"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Fenylbutazon og kortikosteroider"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01BA",
"display": "Antiinflammatory/antirheumatic agents in combination with corticosteroids"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01BA01",
"display": "M01BA01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01BA01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M09AX06",
"display": "Eteplirsen",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Eteplirsen"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Eteplirsen"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M09AX",
"display": "Other drugs for disorders of the musculo-skeletal system"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M09AX06",
"display": "M09AX06"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2017-01-11T00:00:00Z",
"display": "2017-01-11T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M09AX06"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AB",
"display": "Acetic acid derivatives and related substances",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Acetic acid derivatives and related substances"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Eddiksyrederivater og lignende substanser"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01A",
"display": "Antiinflammatory and antirheumatic products, non-steroids"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AB",
"display": "M01AB"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AB"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M03AA04",
"display": "Dimethyltubocurarine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Dimethyltubocurarine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Dimetyltubokurarin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M03AA",
"display": "Curare alkaloids"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M03AA04",
"display": "M03AA04"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M03AA04"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M03AC03",
"display": "Vecuronium",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Vecuronium"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Vekuronium"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M03AC",
"display": "Other quaternary ammonium compounds"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M03AC03",
"display": "M03AC03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M03AC03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M02AA23",
"display": "Indometacin",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Indometacin"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Indometacin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M02AA",
"display": "Antiinflammatory preparations, non-steroids for topical use"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M02AA23",
"display": "M02AA23"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M02AA23"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M03BB72",
"display": "Chlormezanone, combinations with psycholeptics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Chlormezanone, combinations with psycholeptics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Klormezanon, kombinasjoner med psykoleptika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M03BB",
"display": "Oxazol, thiazine, and triazine derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M03BB72",
"display": "M03BB72"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M03BB72"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AB07",
"display": "Bumadizone",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Bumadizone"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Bumadizon"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AB",
"display": "Acetic acid derivatives and related substances"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AB07",
"display": "M01AB07"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AB07"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M03BX02",
"display": "Tizanidine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Tizanidine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Tizanidin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M03BX",
"display": "Other centrally acting agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M03BX02",
"display": "M03BX02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M03BX02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M05BX02",
"display": "Aluminium chlorohydrate",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Aluminium chlorohydrate"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Aluminiumklorhydrat"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M05BX",
"display": "Other drugs affecting bone structure and mineralization"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M05BX02",
"display": "M05BX02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M05BX02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M04AB01",
"display": "Probenecid",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Probenecid"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Probenecid"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M04AB",
"display": "Preparations increasing uric acid excretion"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M04AB01",
"display": "M04AB01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M04AB01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M02AB",
"display": "Capsaicin and similar agents",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Capsaicin and similar agents"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Capsaicin og lignende stoffer"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M02A",
"display": "Topical products for joint and muscular pain"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M02AB",
"display": "M02AB"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M02AB"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M02AA15",
"display": "Diclofenac",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Diclofenac"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Diklofenak"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M02AA",
"display": "Antiinflammatory preparations, non-steroids for topical use"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M02AA15",
"display": "M02AA15"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M02AA15"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M09AB01",
"display": "Chymopapain",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Chymopapain"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Kymopapain"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M09AB",
"display": "Enzymes"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M09AB01",
"display": "M09AB01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M09AB01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AX14",
"display": "Orgotein",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Orgotein"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Orgotein"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AX",
"display": "Other antiinflammatory and antirheumatic agents, non-steroids"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AX14",
"display": "M01AX14"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AX14"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AE08",
"display": "Pirprofen",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Pirprofen"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Pirprofen"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AE",
"display": "Propionic acid derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AE08",
"display": "M01AE08"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AE08"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AX26",
"display": "Avocado and soyabean oil, unsaponifiables",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Avocado and soyabean oil, unsaponifiables"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Avokado- og soyabønneolje, ikke-forsåpbare"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AX",
"display": "Other antiinflammatory and antirheumatic agents, non-steroids"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AX26",
"display": "M01AX26"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2011-01-01T00:00:00Z",
"display": "2011-01-01T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AX26"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M03BX55",
"display": "Thiocolchicoside, combinations",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Thiocolchicoside, combinations"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Tiokolchikosid, kombinasjoner"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M03BX",
"display": "Other centrally acting agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M03BX55",
"display": "M03BX55"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2014-02-20T00:00:00Z",
"display": "2014-02-20T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M03BX55"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M03BB73",
"display": "Chlorzoxazone, combinations with psycholeptics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Chlorzoxazone, combinations with psycholeptics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Klorzoksason, kombinasjoner med psykoleptika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M03BB",
"display": "Oxazol, thiazine, and triazine derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M03BB73",
"display": "M03BB73"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M03BB73"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01BA",
"display": "Antiinflammatory/antirheumatic agents in combination with corticosteroids",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Antiinflammatory/antirheumatic agents in combination with corticosteroids"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Antiinflammatoriske og antireumatiske midler i kombinasjon med kortikosteroider"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01B",
"display": "Antiinflammatory/antirheumatic agents in combination"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01BA",
"display": "M01BA"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01BA"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M03AC02",
"display": "Gallamine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Gallamine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Gallamin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M03AC",
"display": "Other quaternary ammonium compounds"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M03AC02",
"display": "M03AC02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M03AC02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M02AA04",
"display": "Oxyphenbutazone",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Oxyphenbutazone"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Oksyfenbutazon"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M02AA",
"display": "Antiinflammatory preparations, non-steroids for topical use"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M02AA04",
"display": "M02AA04"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M02AA04"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AB17",
"display": "Bufexamac",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Bufexamac"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Bufeksamak"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AB",
"display": "Acetic acid derivatives and related substances"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AB17",
"display": "M01AB17"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AB17"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01CB03",
"display": "Auranofin",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Auranofin"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Auranofin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01CB",
"display": "Gold preparations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01CB03",
"display": "M01CB03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01CB03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M04AB03",
"display": "Benzbromarone",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Benzbromarone"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Benzbromaron"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M04AB",
"display": "Preparations increasing uric acid excretion"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M04AB03",
"display": "M04AB03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M04AB03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AG04",
"display": "Meclofenamic acid",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Meclofenamic acid"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Meklofenamsyre"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AG",
"display": "Fenamates"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AG04",
"display": "M01AG04"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AG04"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M09AX12",
"display": "Viltolarsen",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Viltolarsen"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Viltolarsen"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M09AX",
"display": "Other drugs for disorders of the musculo-skeletal system"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M09AX12",
"display": "M09AX12"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2021-03-04T00:00:00Z",
"display": "2021-03-04T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M09AX12"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AA03",
"display": "Oxyphenbutazone",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Oxyphenbutazone"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Oksyfenbutazon"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AA",
"display": "Butylpyrazolidines"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AA03",
"display": "M01AA03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AA03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M03BX05",
"display": "Thiocolchicoside",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Thiocolchicoside"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Tiokolchikosid"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M03BX",
"display": "Other centrally acting agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M03BX05",
"display": "M03BX05"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M03BX05"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01CC02",
"display": "Bucillamine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Bucillamine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Bucillamin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01CC",
"display": "Penicillamine and similar agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01CC02",
"display": "M01CC02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01CC02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M02AA17",
"display": "Niflumic acid",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Niflumic acid"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Nifluminsyre"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M02AA",
"display": "Antiinflammatory preparations, non-steroids for topical use"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M02AA17",
"display": "M02AA17"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M02AA17"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M05BX07",
"display": "Vosoritide",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Vosoritide"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Vosoritid"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M05BX",
"display": "Other drugs affecting bone structure and mineralization"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M05BX07",
"display": "M05BX07"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2021-03-04T00:00:00Z",
"display": "2021-03-04T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M05BX07"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M05BC01",
"display": "Dibotermin alfa",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Dibotermin alfa"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Dibotermin alfa"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M05BC",
"display": "Bone morphogenetic proteins"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M05BC01",
"display": "M05BC01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2003-03-14T00:00:00Z",
"display": "2003-03-14T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M05BC01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M03AA01",
"display": "Alcuronium",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Alcuronium"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Alkuron"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M03AA",
"display": "Curare alkaloids"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M03AA01",
"display": "M03AA01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M03AA01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AB04",
"display": "Zomepirac",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Zomepirac"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Zomepirak"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AB",
"display": "Acetic acid derivatives and related substances"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AB04",
"display": "M01AB04"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AB04"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M03BA72",
"display": "Carisoprodol, combinations with psycholeptics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Carisoprodol, combinations with psycholeptics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Karisoprodol, kombinasjoner med psykoleptika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M03BA",
"display": "Carbamic acid esters"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M03BA72",
"display": "M03BA72"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M03BA72"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M03AC11",
"display": "Cisatracurium",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Cisatracurium"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Cisatrakurium"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M03AC",
"display": "Other quaternary ammonium compounds"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M03AC11",
"display": "M03AC11"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M03AC11"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M05BA",
"display": "Bisphosphonates",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Bisphosphonates"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Bisfosfonater"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M05B",
"display": "Drugs affecting bone structure and mineralization"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M05BA",
"display": "M05BA"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M05BA"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AE05",
"display": "Fenbufen",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Fenbufen"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Fenbufen"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AE",
"display": "Propionic acid derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AE05",
"display": "M01AE05"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AE05"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M04AC01",
"display": "Colchicine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Colchicine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Kolkisin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M04AC",
"display": "Preparations with no effect on uric acid metabolism"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M04AC01",
"display": "M04AC01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M04AC01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AA06",
"display": "Kebuzone",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Kebuzone"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Kebuzon"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AA",
"display": "Butylpyrazolidines"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AA06",
"display": "M01AA06"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AA06"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M05BX53",
"display": "Strontium ranelate and colecalciferol",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Strontium ranelate and colecalciferol"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Strontiumranelat og kolekalsiferol"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M05BX",
"display": "Other drugs affecting bone structure and mineralization"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M05BX53",
"display": "M05BX53"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2013-12-10T00:00:00Z",
"display": "2013-12-10T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M05BX53"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01CC01",
"display": "Penicillamine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Penicillamine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Penicillamin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01CC",
"display": "Penicillamine and similar agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01CC01",
"display": "M01CC01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01CC01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M05BX01",
"display": "Ipriflavone",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Ipriflavone"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Ipriflavon"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M05BX",
"display": "Other drugs affecting bone structure and mineralization"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M05BX01",
"display": "M05BX01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M05BX01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AB08",
"display": "Etodolac",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Etodolac"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Etodolak"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AB",
"display": "Acetic acid derivatives and related substances"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AB08",
"display": "M01AB08"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AB08"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M05BB01",
"display": "Etidronic acid and calcium, sequential",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Etidronic acid and calcium, sequential"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Etidronsyre og kalsium, sekvensielle"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M05BB",
"display": "Bisphosphonates, combinations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M05BB01",
"display": "M05BB01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M05BB01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01CB02",
"display": "Sodium aurotiosulfate",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Sodium aurotiosulfate"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Natriumaurotiosulfat"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01CB",
"display": "Gold preparations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01CB02",
"display": "M01CB02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01CB02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AH02",
"display": "Rofecoxib",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Rofecoxib"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Rofekoksib"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AH",
"display": "Coxibs"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AH02",
"display": "M01AH02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AH02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AE04",
"display": "Fenoprofen",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Fenoprofen"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Fenoprofen"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AE",
"display": "Propionic acid derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AE04",
"display": "M01AE04"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AE04"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "M01AE02",
"display": "Naproxen",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Naproxen"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Naproksen"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/82311936-f7e3-4c24-8821-229f055f7c64",
"code": "M01AE",
"display": "Propionic acid derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "M01AE02",
"display": "M01AE02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "M01AE02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
}
]
}